Ensoma Appoints Accomplished Company Builder and Product Developer, Jim Burns, Ph.D., as Chief Executive Officer

News
2024
2023
Archive
Search news articles

May 30, 2012

FLEXION’S LEAD OSTEOARTHRITIS DRUG CANDIDATE DEMONSTRATES SIGNIFICANT, PROLONGED IMPROVEMENT IN PAIN AND FUNCTION IN PHASE 2 TRIAL
May 28, 2012

THE VIVEVE SYSTEM RECEIVES HEALTH CANADA MEDICAL DEVICE LICENSE TO NON-SURGICALLY TREAT VAGINAL LAXITY FOLLOWING CHILDBIRTH
May 21, 2012

PEARL THERAPEUTICS RECEIVES TIE50 AWARD FROM GLOBAL ENTREPRENEURSHIP NETWORK
May 15, 2012

WILDCAT DISCOVERY TECHNOLOGIES ARTICLE IN MAY/JUNE 2012 TECHNOLOGY REVIEW
May 15, 2012

ACHAOGEN ANNOUNCES ALL OBJECTIVES MET IN PHASE 2 PLAZOMICIN COMPLICATED URINARY TRACT INFECTIONS STUDY AND START OF FIRST-IN-HUMAN STUDY WITH ACHN-975
May 7, 2012

MICHAEL J. FOX FOUNDATION EXPANDS FUNDING TO ENVOY
April 27, 2012

WILDCAT DISCOVERY TECHNOLOGIES NAMED ONE OF TECHNOLOGY REVIEW’S 2012 TOP 50 MOST INNOVATIVE COMPANIES
March 22, 2012

ANAPHORE ANNOUNCES ACQUISITION OF RUIYI IN SHANGHAI CHINA FOR GPCR BIOLOGICS DRUG DISCOVERY PLATFORM
March 13, 2012

FLEXION ARTICLE: COULD THIS BE ORTHOPEDICS’ FUTURE?, ORTHOPEDICS THIS WEEK, 8 (9)
March 5, 2012

DATA PRESENTED AT THE 2012 EUROPEAN CONGRESS OF PSYCHIATRY SHOWING THAT SELINCRO(TM) REDUCES TOTAL ALCOHOL CONSUMPTION BY TWO-THIRDS ON AVERAGE AFTER SIX MONTHS OF TREATMENT